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Abstract
Background: Schizophrenia is a debilitating and complex mental disorder whose exact etiology remains unknown.
There is growing amount of evidence of a relationship between neuroinflammation, as demonstrated by microglial
activation, and schizophrenia. Our previous studies have proposed that hyperbilirubinemia plays a role in the
pathophysiology of schizophrenia. Furthermore, we suggested the Gunn rat, an animal model of bilirubin
encephalopathy, as a possible animal model of schizophrenia. However, the effects of unconjugated bilirubin on
microglia, the resident immune cell of the CNS, in Gunn rats have never been investigated. In the present study,
we examined how microglial cells respond to bilirubin toxicity in adult Gunn rats.
Methods: Using immunohistochemical techniques, we compared the distribution, morphology, and ultrastructural
features of microglial cells in Gunn rats with Wistar rats as a normal control. We also determined the ratio of
activated and resting microglia and observed microglia-neuron interactions. We characterized the microglial cells in
the hippocampal dentate gyrus.
Results: We found that microglial cells showed activated morphology in the hilus, subgranular zone, and granular
layer of the Gunn rat hippocampal dentate gyrus. There was no significant difference between cell numbers
between in Gunn rats and controls. However, there was significant difference in the area of CD11b expression in
the hippocampal dentate gyrus. Ultrastructurally, microglial cells often contained rich enlarged rich organelles in
the cytoplasm and showed some phagocytic function.
Conclusions: We propose that activation of microglia could be an important causal factor of the behavioral
abnormalities and neuropathological changes in Gunn rats. These findings may provide basic information for
further assessment of the Gunn rat as an animal model of schizophrenia.
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Introduction
Schizophrenia is a complex and debilitating mental dis-
order with a prevalence of approximately 1% worldwide.
In addition to severely disrupting the life of patients and
their families, schizophrenia imposes a great cost on
society in terms of productivity loss and treatment-
related expense. Schizophrenia is still a major challenge
in psychiatry, in part because the exact etiology remains
unknown [1,2].
Recent genome-wide studies in schizophrenia have
shown the association of schizophrenia with markers in
the major histocompatibility complex (MHC) region and
suggest immune system involvement in schizophrenia
[3]. An accumulating body of evidence point to the sig-
nificance of neuroinflammation and immunogenetics in
schizophrenia, characterized by an increased serum con-
centration of several proinflammatory cytokines [4]. Per-
ipheral inflammatory responses in schizophrenia have
also been linked to aberrations in circulating monocytes
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any medium, provided the original work is properly cited.and T cells [5]. Interestingly, microglial activation or
increased microglial cellular density has also been sug-
gested by postmortem studies, at least in subpopulations
of individuals with schizophrenia [6,7]. Moreover, a
proinflammatory immune state influences the glutama-
tergic neurotransmission indirectly by bits effects on the
tryptophan/kynurenine metabolism. The immune
response in schizophrenia seems to be associated with
the activation of the enzyme indoleamine 2,3-dioxygen-
ase (IDO) and imbalance in tryptophan/kynurenine
metabolism resulting in increased production of kynure-
nic acid in the brain. This is associated with an imbal-
ance in the glutamatergic neurotransmission, leading to
an N-methyl-D-aspartate (NMDA) antagonism in schi-
zophrenia [8,9].
Previous studies showed a link between hyperbilirubi-
nemia and schizophrenia. Schizophrenia patients have a
significantly higher frequency of hyperbilirubinemia rela-
tive to patients with other psychiatric disorders and the
general healthy population [10-12]. Moreover, in brain
imaging studies, we found severer brain metabolism
abnormalities in patients with schizophrenia associated
with idiopathic unconjugated hyperbilirubinemia (Gil-
bert’s syndrome (GS)) compared to both schizophrenia
patients without GS and normal controls [13-16]. Based
on these facts, we propose that hyperbilirubinemia may
play a role in the pathophysiology of schizophrenia.
Hyperbilirubinemia is a common condition in the
neonatal period that results from decreased erythrocyte
survival and defective hepatic clearance of unconjugated
bilirubin (UCB). Accumulation of UCB in the central
nervous system (CNS) is the major cause of transient
bilirubin encephalopathy and of a more critical condi-
tion, called ‘kernicterus’, which can result in a newborn
infant’s death [17-20]. Additionally, neonatal hyperbiliru-
binemia might be a vulnerability factor for later mental
disorder [21].
Our previous study showed behavioral abnormalities,
deficits in prepulse inhibition (PPI), and neuropathologi-
cal changes in Gunn rats that are similar to the charac-
teristics of schizophrenia [22]. The Gunn rat, a mutant
of the Wistar strain [23], has a genetic deficiency in glu-
curonyl transferase and has been used as an animal
model of bilirubin encephalopathy. We found that a
high serum UCB concentration has a pathogenic effect
on development of the brain and concluded that the
Gunn rat may be used as an animal model of schizo-
phrenia [22].
UCB in the CNS is toxic to neurons and associated
microglia, the resident immune cells in the CNS
[24-26]. However, the effects of UCB on microglia in
Gunn rats have never been investigated. Therefore, in
the present study, we sought to examine how microglial
cells respond to UCB toxicity in Gunn rats. We
hypothesized that UCB toxicity induces microglia activa-
tion and that prolonged microglial activation plays a
role that makes the Gunn rat suitable as an animal
model of schizophrenia. We observed the morphological
features, distribution, and ultrastructural characteristics
of microglial cells in adult Gunn rats. We also deter-
mined the ratio of resting/ramified cells to activated
c e l l sa n de x a m i n e dt h en e u r o n -microglia interactions.
These studies were performed on the hippocampal den-
tate gyrus (DG), and the results were compared to those
to Wistar rats as a normal control.
Methods
Animals
The animals were male homozygous (j/j) Gunn rats and
male Wistar rats (N = 10 each, Japan SLC, Inc., Shi-
zuoka, Japan) that were 8 weeks old at the time of the
experiments. Gunn j/j rats were born to female Gunn j/j
and male +/j rats at Japan SLC, Inc. The rats were
housed under standard conditions with a room tempera-
t u r eo f2 3±2 ° C ,h u m i d i t yo f5 5±5 % ,a n d1 2hl i g h t ,
12 h dark cycle (light phase 7:00 to 19:00) and were
given free access to food and water. Starting 1 week
before the beginning of the experiment, the rats under-
went a handling procedure once that was aimed at redu-
cing experimental stress. The handling procedure
consisted of picking the rat up with a gloved hand and
stroking it for 10 minutes. All procedures were per-
formed with the approval of the Shimane University
Animal Ethics Committee, under the guidelines of the
National Health and Medical Research Council of Japan.
Under deep intraperitoneal anesthesia with sodium
pentobarbital (80 mg/kg body weight), the rats were per-
fused transcardially with 500 ml of physiological saline,
followed by 500 ml of 4% paraformaldehyde in 0.1 M
phosphate buffer (PB; pH 7.3). After perfusion, the brain
was quickly removed, post fixed in a solution of 4% par-
aformaldehyde at room temperature for 4 h, and then
immersed overnight in a cold solution of 20% sucrose.
Later, the brains were cut in at 50 μm thick in the fron-
tal plane using a freezing microtome.
Immunohistochemistry for light and confocal laser
scanning microscopy
Sections used for immunohistochemistry were incubated
in 1% H2O2 for 30 minutes, then were rinsed twice for
15 minutes in PBS. Free-floating sections were preincu-
bated with 1.5% normal goat serum, 0.2% Triton-X in
0.1 M PB (pH 7.3) for 1 h rotating at room temperature
(RT). Sections were then incubated overnight rotating at
RT with primary antibody in preincubation solution.
The following primary antibodies were used: rabbit anti-
ionized calcium binding adaptor molecule 1 (Iba1)
(1:4,000, Wako Ltd., Osaka, Japan) and mouse anti-
Liaury et al. Journal of Neuroinflammation 2012, 9:56
http://www.jneuroinflammation.com/content/9/1/56
Page 2 of 11CD11b (1:500, AbD Serotec, Oxford, UK). The sections
were then rinsed twice for 15 minutes in phosphate-buf-
fered saline (PBS) and incubated for 1 h in biotinylated
anti-rabbit (or anti-mouse) IgG (1:200, Standard ABC
Kit, Vector Labs, Burlingame, CA, USA) solution, rotat-
ing at RT. The sections were then rinsed twice for 15
minutes in PBS and incubated for 1 h in PBS containing
avidin-biotin peroxidase complex (ABC) (Standard ABC
Kit, Vector Labs) solution rotating at RT. After being
rinsed twice for 15 minutes in PBS, the sections were
developed by incubating in PBS containing 10 mg diami-
nobenzidine (DAB) and 5 μl of 30% hydrogen peroxide for
10 minutes. The DAB reaction was halted using PBS, fol-
lowed by two 15-minute PBS rinses. The tissue was
mounted onto gelatin-coated slides, dehydrated in graded
alcohol baths, and coverslips (Matsunami Glass Ind., Ltd.,
Osaka, Japan) were applied using mounting medium. For
Nissl staining, the sections were stained with 0.5% cresyl
violet, dehydrated, delipidated in xylene, and coverslipped.
For double immunofluorescent labeling, sections were
incubated free floating in secondary antibodies: mouse
anti-CD11b (1:500, Serotec), or mouse anti-NeuN (neuro-
nal nuclei) antibody (1:200, Millipore Inc., Temecula, CA,
USA) with 1.5% normal goat serum, 0.2% Triton-X in 0.1
M PB overnight rotating at RT. Subsequently, the sections
were rinsed twice for 15 minutes in PBS, then were incu-
bated in PBS containing Cy3-conjugated anti-rabbit IgG
for Iba1 (Amersham Bioscience Ltd., Piscataway, NJ, USA)
d i l u t e da t1 : 1 , 0 0 0a n dA l e x a 4 8 8 - c o n j u g a t e da n t i - m o u s e
IgG for CD11b (Invitrogen, Carlsbad, CA, USA) diluted at
1:1,000 for 1 h.
Iba1-immunoelectron microscopy
Rats were perfused transcardially with a solution com-
posed of 4% paraformaldehyde and 0.1% glutaraldehyde
in 0.1 M PB (pH 7.3), and the brain was quickly removed,
post fixed in a solution of 4% paraformaldehyde at room
temperature for 4 h, and then immersed overnight in a
cold solution of 20% sucrose in 0.1 M PB (pH 7.3). Then,
the hippocampus area was dissected out and cut at 50
μm thickness in the frontal plane using a vibratome
microtome. The sections were incubated overnight with
rabbit anti-Iba1 (1:4,000, Wako) in preincubation solu-
tion rotating at RT. After being rinsed in PBS, the sec-
tions were incubated for 1 h in biotinylated anti-rabbit
IgG (1:200), Vector Labs), rinsed in PBS, and then incu-
bated for 1 h in PBS containing ABC (Standard ABC Kit,
Vector Labs). The sections were then rinsed in PBS and
incubated in PBS containing 10 mg DAB and 5 μlo f3 0 %
hydrogen peroxide. Later the sections were post fixed in
a solution of 1% osmium tetroxide in 0.1 M PB (pH 7.3)
for 30 minutes at RT. After washing in distilled water,
the sections were stained en bloc with 0.5% uranyl acet-
ate in 70% ethanol for 1 h, dehydrated in a graded series
of ethanols, cleared in propylene oxide, and then
embedded flat in Epon. Subsequently, serial ultrathin sec-
tions were cut on an ultramicrotome, collected on collo-
dion-coated copper grids, and stained with lead citrate.
Finally, the sections were examined under an electron
microscope (JEOL JEM1200EX).
Counting Iba1-labeled microglial cells in DG
To estimate the numbers of Iba1 expressing microglial
cells, images were captured from four areas within the
hippocampal DG: hilus, subgranular zone (SGZ), granu-
lar layer (GL), and molecular layer (ML). A 55 × 55 μm
box was then randomly placed within each region of
interest from interaural 5.88 mm, bregma -3.12 mm,
interaural 4.20 mm, and bregma -4.80 mm, based on
the atlas of the rat brain [27]. There were about 450
boxes per region in each sample at each analysis. The
images were analyzed using Stereo Investigator software
V. 7.0 (MicroBrightfield Inc., Williston, VT, USA). The
software automatically calculates the number of Iba1-
labeled cells within the region of interest.
Measuring CD11b-labeled microglial cells immunoreactive
area
The immunoreactive area was measured using a compu-
ter-assisted image analysis program (Image Tool V. 3.0,
Department of Dental Diagnostic Science, University of
Texas Health Science Center, San Antonio, Texas, USA).
Sections containing CD11b-labeled cells were examined
under a light microscope (Nikon, ECLIPSE E800). Images
(N = 40 per region examined, per time point) were ran-
domly captured from the same region of interest used in
the cell counting procedure, and these areas were used
for analysis. The images were analyzed using the Image-
Tool software, which automates the analysis by convert-
ing all immunolabeled elements that fall within a
threshold range into pure black pixels and the rest of the
image into pure white pixels. The software then quanti-
fies the total number and percentages of black and white
pixels, allowing for statistical analysis of the data.
Statistical analysis
Statistical analysis was performed with SPSS software
(Dr. SPSS II for Windows V. 11.0, SPSS Inc., Chicago.
IL, USA) and the results were presented as the mean ±
SEM. Differences between Gunn rats and controls were
compared using the two-tailed Student’s t test with P of
< 0.005 considered to be a significant difference.
Results
Light and confocal microscopy of Iba1-labeled microglial
cells
We found Iba1-labeled microglial cells throughout the
hilus and in the SGZ, GL, and ML in the hippocampal
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elongated cell somata with fewer branches but thicker
processes in the hilus, SGZ, and GL (Figure 2A). This
kind of morphology is known as activated morphology
[28]. However, in the ML cells showed small rod-shaped
somata with numerous thin and highly ramified pro-
cesses. This kind of morphology is known as ramified/
resting morphology [29] and is similar to the morphology
found in Wistar rats (Figure 2B). Iba1-labeled cells in the
GL were relatively infrequent both in Gunn and Wistar
rats. However, a concentration of Iba1-labeled cells was
found at the SGZ with processes extending into the GL.
Some Iba1-labeled cells in Gunn rats were observed in
apposition to NeuN-labeled neuronal cell bodies (Figure
3). These Iba1 cells showed morphology of the activated
type with processes that try to wrap around the neuron
cell body.
Then we counted the Iba1-labeled cell numbers using
the Stereo Investigator software. We captured about 450
sites, and counted for approximately 2 to 3 Iba1-labeled
cells per site. The software then automatically estimated
automated the cell numbers. Our result showed no sig-
nificant difference between Gunn and Wistar rats in the
estimated numbers of Iba1-labeled cells in all areas of
the DG (Figure 4).
Electron microscopy of Iba1-labeled microglial cells
Ultrastructurally, Iba1-labeled cell bodies in the DG were
identified by an electron-dense immunoreactive product
within their perikaryal cytoplasm [30]. Activated Iba1-
labeled cells have an elongated cell body and enlarged
cytoplasm (Figure 5). There was an increased electron
density in the periphery of the cytoplasm. We also
observed an organelle-rich cytoplasm that includes the
Golgi apparatus, lysosomes, rough endoplasmic reticulum,
and some small vesicles containing low-density material.
Another interesting finding was the phagocytic func-
tion of microglia. We show two examples of microglial
Figure 1 Hippocampal dentate gyrus (DG) of Gunn rat. Immunolabeling using ionized calcium binding adaptor molecule 1 (Iba1)/Nissl
staining. Scale bars: 0.5 mm (left); 0.1 mm (right).
Figure 2 Confocal photomicrographs of ionized calcium binding adaptor molecule 1 (Iba1)-labeled microglial cells in dentate gyrus
(DG). A confocal Z-stack merged image depicting Iba1-labeled cell bodies (red), processes, and distribution in the DG in Gunn rats (A) and
Wistar rats as a normal control (B). Immunolabeling using Iba1/NeuN staining. Scale bars: 50 μm.
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cells and neuronal somata. Immunolabeling using ionized calcium binding adaptor molecule 1 (Iba1)/NeuN staining. Scale bars: 50 μm.
Figure 4 Estimated ionized calcium binding adaptor molecule 1 (Iba1)-labeled microglial cell numbers in dentate gyrus (DG).At w o -
tailed t test did not reveal any significant difference between Gunn and Wistar rats in any DG samples. Data are presented as mean ± SEM. Area
of hippocampus: hilus; ML = molecular layer; GL = granular layer; SGZ = subgranular zone.
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a tt h ee n d so ft h ep r o c e s s e s( F i g u r e6 ) .T h i sk i n do f
phagocytic pouch is known as a modification of the pha-
gocytosis function of microglial processes [31]. These
phagocytic pouches seemed to attach to damaged or
broken cells. There were rich organelles inside the
pouches, and strong immunoreaction products were
observed in the peripheral cytoplasm (Figure 6A, B).
Finally, macrophage-like microglial cells were observed
in the dentate gyrus of Gunn rats. Two examples of
Iba1-labeled macrophage-like cells with large phagocytic
vacuoles/vesicles are shown in Figure 7. We can still
observe the immunoreactive product around the cells,
but no more organelle-rich cytoplasm is seen.
CD11b expression in Iba1-labeled microglial cells
Next, we examined the expression of a marker that
increases during microglia activation, CD11b (integrin a
M) [31]. The expression of CD11b in Iba1-labeled
microglial cells in the DG of Gunn rats was compared
to its expression in Wistar rats as normal controls (Fig-
ure 8). Our result showed that microglial cells in Gunn
rats expressed high levels of CD11b immunoreactivity
(Figure 8A3, 8A4). Interestingly, some of the positive
CD11b microglial cells were bunched together in the
SGZ. In contrast, microglial cells in Wistar rats did not
show significant CD11b expression (Figure 8B3, 8B4).
Furthermore, we determined the mean percentages of
the CD11b expression areas in the hilus, SGZ, GL, and
ML of DG. Statistical analysis showed that areas of
CD11b expression were significantly greater in Gunn
rats than in Wistar rats in the hilus (P <0 . 0 0 5 ) ,S G Z( P
<0 . 0 0 1 ) ,a n dG L( P <0 . 0 0 5 ) .T h e r ew e r en os i g n i f i c a n t
difference of CD11b expression in the ML between
Gunn rats and Wistar rats (Figure 9).
Discussion
In the present study, we demonstrated the morphologi-
cal features of microglial cells in the DG of Gunn rats
for the first time. We used immunofluorescent labeling
Figure 5 Electron micrographs of ionized calcium binding adaptor molecule 1 (Iba1)-labeled microglial cells in the hilus area of Gunn
rat. Arrows represent the increased electron density at the periphery of cytoplasm; arrowheads represent small vesicles containing low-density
material. Scale bars: 2 μm. G = Golgi apparatus; Ly = lysosome; N = nucleus; rER = rough endoplasmic reticulum.
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CD11b to observe phagocytic microglial activation [31].
First, we revealed that Iba1-labeled microglial cells
showed activated morphology in the DG of Gunn rats.
Second, during ultrastructural observation, we found
that these activated cells contained enlarged areas of
cytoplasm rich in organelles, and that some of them
formed phagocytic pouches or engulfed large phagocytic
vacuoles. Third, there was significant difference in
CD11b expression areas in the DG of Gunn rats com-
pared to controls.
Microglial cells are generally considered to be the
immune cells of the CNS and perform the function of
monitoring and protecting the well-being of neurons
[32,33]. Under normal conditions, the number of micro-
glia is limited, comprising 20% of the total glial cell
population in the brain, and are characterized by a small
cell body with fine, ramified processes, and low
expression of surface antigens [33,34]. When the CNS is
injured, microglia rapidly shift into an activated state
and migrate to the damaged sites. Activated microglia
are marked by a number of characteristic events, affect-
ing cellular morphology, cell size, cell number, and at
the molecular level, the pattern of cell surface molecules
expressed (immunophenotype) as well as the pattern of
cytokines and growth factors produced, which distin-
guish them from the resting/ramified phenotype [34,35].
Microglial cells are well known to interact with neu-
rons. Microglia are able to regulate several aspects of
neuronal functions, and neurons can control microglia
activation [36]. Microglial cells respond to signals from
injured neurons, which shift them into activated states,
in close apposition to the injured neuron in order to
release either neurotropic or neurotoxic factors [35].
Our result found that some microglial cells were
apposed to neurons and showed activated morphology.
Figure 6 ionized calcium binding adaptor molecule 1 (Iba1)-labeled microglial cells with phagocytic pouch in Gunn rat. Somata of Iba1-
labeled cells with extended processes and phagocytic pouch attached to damaged/broken cells (*). Arrows indicate immunoreactive products.
Notice the plentiful organelles within the pouch. Scale bars: 2 μm (A, B), 1 μm( A ’,B ’). G = Golgi apparatus; GCL = granular cell layer; Ly =
lysosome; N = nucleus; P = phagocytic pouch; Pr = process.
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UCB toxicity, and therefore induced microglia
activation.
An additional highly characteristic feature of microglia
activation is the remarkable capacity of the microglial
cell population to expand, especially in response to
acute injury [37]. This expansion is usually transient and
has been considered to be due predominantly to prolif-
eration of activated resident microglia [35,38]. Our
result showed no significant difference between Iba1-
labeled microglial cell numbers in Gunn rats and in
controls. However, we found a significant difference in
the area of CD11b expression as marker of microglial
activation. These results suggest that microglial cells in
Figure 7 Electron micrographs of ionized calcium binding adaptor molecule 1 (Iba1)-labeled macrophage-like cells in Gunn rat.T w o
examples of macrophage-like cells with large phagocytic vacuole/vesicle (*). Arrows indicate the immunoreactive products. Scale bars: 1 μm.
Figure 8 CD11b expression in ionized calcium binding adaptor molecule 1 (Iba1)-labeled microglial cells. A confocal Z stack image
depicting Iba1-labeled (red), CD11b expression (green), and merged (yellow) cells of a Gunn rat (A1-A4) compared to those of a Wistar rat (B1-
B4) in the hippocampal dentate gyrus (DG). Microglial cells in Gunn rats expressed a high level of CD11b immunoreactivity compared to those
of Wistar rats. Scale bars: 200 μm (A1, B1), 20 μm (A2-A4, B2-B4).
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tion without expansion of the cell population.
Homozygous (j/j) Gunn rats have an inherited defi-
ciency of hepatic UDP-glucuronyl transferase and there-
fore are unable to adequately conjugate and excrete
bilirubin. This condition develops into severe hyperbilir-
ubinemia, with visible jaundice within 6 h of parturition,
and thus manifests a pattern of brain injury that resem-
bles the histopathology of neuronal injury associated
with bilirubin encephalopathy in humans. This bilirubin
neurotoxicity may persist through their entire lives
[39,40]. In homozygous (j/j) Gunn rats, few signs of
bilirubin toxicity are present during the first postnatal
weeks [41]. Our previous study found that blood biliru-
bin levels in adult Gunn rats were still high [22] and the
presence of microglia activation suggested the possibility
of chronic neuronal inflammation. When acute micro-
glial activation becomes a chronic condition following
injury, the microglial cells is potentially maladaptive or
neuroprotective [42]. We suggest that chronic microglial
activation in adult Gunn rats is potentially more mala-
daptive than neuroprotective.
Prolonged microglia activation of microglia may lead
to neuronal degeneration, white matter abnormalities,
decreased neurogenesis, apoptosis, and brain damage,
and may thus be one of the important factors in the
pathophysiology of schizophrenia [2]. Moreover, a pre-
vious positron emission tomography study showed sig-
nificant neuroinflammation in the hippocampus of
schizophrenic patients compared with healthy volunteers
[43]. Increased serum concentrations of proinflamma-
tory cytokines have been observed in schizophrenia
patients [44,45]. In clinical practice, immunomodulatory
drugs such as cyclo-oxygenase 2 and minocycline have
been reported to have beneficial effects on schizophrenia
treatment [46,47]. Moreover, it was reported that atypi-
cal antipsychotics may have anti-inflammatory effects on
microglial activation [48,49].
Conclusions
In summary, our results showed evidence of microglial
activation within the brains of adult Gunn rats. We sug-
gest that the chronic microglial activation due to UCB
toxicity could be considered an important causal factor
in the behavioral abnormalities and neuropathological
changes in Gunn rats. Moreover, our result may provide
crucial information to elucidate the etiology of schizo-
phrenia and support the possibility of using Gunn rats as
an animal model of schizophrenia. However, the exact
mechanism of chronic microglial activation in Gunn rats
is still unclear. Future studies are needed to elucidate the
mechanism of UCB toxicity in neurons and microglia.
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